Other Issues

Browse Other Issues Content

OTC medical devices like bandages, menstrual products, face masks, and at-home test kits, used for the purposes of prevention, testing, and treatment are well-accepted, cost saving elements of the healthcare system. Unfortunately, most states that have a retail sales tax, include a tax on the sale of some or all OTC healthcare products. More than 40 states, on the other hand, exempt sales tax of prescription drugs.

Nov 19, 2024

CHPA supports FDA’s continued efforts to support medical device innovation by facilitating to the use of PCCPs for efficient Agency review of medical device modifications. When finalizing the Draft Guidance, CHPA strongly encourages FDA to provide further clarity regarding the content and process for PCCPs on several points.

Nov 19, 2024

CHPA supports the Agency’s directive to increase enrollment of participants from historically underrepresented populations in clinical trials to improve the strength and generalizability of the evidence to demonstrate safety and/or effectiveness of FDA-regulated medical products, but requests clarification on several points.

Oct 29, 2024

Despite the critical role sunscreens play in a healthy self-care routine, some state lawmakers are working to restrict sales of chemical sunscreens and key ingredients due to perceived environmental and human health impacts.

Oct 1, 2024

The Consumer Healthcare Products Association (CHPA) released the following statement today in response to Aylstock, Witkin, Kreis & Overholtz, PLLC filing a Citizen Petition with the U.S. Food and Drug Administration (FDA), requesting the Agency “recall and suspend sales of benzoyl peroxide (BPO) from the US Market due to the presence of benzene.”

Aug 21, 2024

In recent years, several states have taken proactive steps to address plastic pollution and promote sustainability by implementing post-consumer recycled (PCR) content mandates for packaging. These laws require manufacturers to incorporate a minimum percentage of recycled materials in their packaging products.

Jul 9, 2024

CHPA and several of its member companies who manufacture and market leading over-the-counter oral care products, including Colgate-Palmolive, Haleon, Kenvue, Lornamead, Procter & Gamble, and Sanofi, joined Members of Congress on Capitol Hill this week to celebrate the introduction of HR 8599, the Oral Health Products Inclusion Act. 

Jun 14, 2024

CHPA released the following statement today applauding the introduction of HR 8599, the Oral Health Products Inclusion Act. This bipartisan legislation, sponsored by U.S. Reps. Jeff Van Drew (NJ-02), Brad Schneider (IL-10), Nicole Malliotakis (NY-11), and Jimmy Panetta (CA-19), would increase access to certain oral care items, including manual and electric toothbrushes, water flossers, anti-cavity toothpaste, mouthwash, and similar oral care products by recognizing them as “qualified medical expenses” that can be purchased with Flexible Spending Account (FSA) and Health Savings Account (HSA) funds. Extending eligibility to oral care products so Americans can better manage their unique oral care needs builds upon a previous bipartisan victory in 2020, which reinstated FSA/HSA eligibility for OTC medicines, and for the first time, feminine care products, as part of the Coronavirus Aid, Relief, and Economic Security (CARES) Act.

Jun 4, 2024

Filter Results